跳至主要内容
临床试验/NCT03085342
NCT03085342Unknown不适用

Evaluation of Hepatic Fibrosis on Multiparametric MRI Including Portal Flow Measurement Using Dual-input Software: Preliminary Study

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2017年4月4日最近更新:
适应症

试验速览

阶段
不适用
入组人数
49
试验地点
1
主要终点
hepatic fibrosis stage

研究概览

简要总结

As cirrhosis progresses, alteration of hemodynamics develops and decreased portal flow is often observed. Since direct measurement of portal pressure (HVPG) is invasive, non-invasive methods have drawn a lot of attention. MRI is one of the non-invasive methods and it is able to provide multiparametric data in one examination. Herein, we evaluate hepatic fibrosis with different stage using multiparametric MRI with emphasis on portal flow measurement.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic liver disease (viral hepatitis, alcoholic hepatitis, or other...)
  • Or transplant recipient for viral hepatitis and on anti-viral agent medication
  • AND scheduled for liver resection, biopsy or transient elastography
  • AND signed informed consent

排除标准

  • younger than 18 years
  • any contra-indication for contrast-enhanced MRI
  • pregnant or nursing women
  • biliary obstruction
  • unable or unwilling to give informed consent

结局指标

主要结局

hepatic fibrosis stage

时间窗: 1 month after MRI

F0-1 vs. F2-4 using multiparametric MRI

次要结局

  • presence of varix(1 month after MRI)
  • comparison of portal flow measurement(1 month after MRI)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Min Lee

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验